Palmer Joycelynne M.: Blood/Marrow Transplantation for Treat

While treatment is believed to influence disease outcome, the wide variation in published survival and remission rates among chronic myeloid leukemia (CML) patients demonstrates that the effectiveness of treatment appears to be modified by patient characteristics, disease features, and disease management approaches. Future improvements in the treatment of CML are dependent on our ability to distinguish between patients who are likely to have long-term disease free survival and those who are not. Between June 1982 and December 2002, 234 patients ...